http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H10167976-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b065102cea3bac2ebedde93bf4a79007
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-899
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
filingDate 1997-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed6ff6208dd4aa5d96105a4f8294b2d0
publicationDate 1998-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H10167976-A
titleOfInvention Immune activator and regenerating activator for normalizing damaged tissues
abstract (57) [Summary] [Problem] In old age, the ability of immunity to eliminate pathogens such as bacteria and viruses rapidly declines, and the ability of non-self-recognition of immune cells to decline causes self organs to weaken and cause pathogens. The reserve capacity to withstand intrusion is reduced. Also, reverse eyelashes, Aging phenomena such as hair growth at the entrance of the ear canal and occurrence of arrhythmia also occur. These phenomena are solved by an immunity enhancer having no side effects and an immunity enhancer for preventing aging. Another object of the present invention is to increase the activity of cells at the damaged site in the human body, and to increase the range of types of normalizable and reproducible sites and their recovery levels. SOLUTION: The decrease in immunity and the aging phenomenon, that is, the decrease and mutation of cell function, are combined with the action of trace amounts of various hormones originally possessed by human beings with extremely high activity, thereby increasing the amount of endogenous prostaglandin. By taking an immunopotentiator consisting of cisapride, cisapride and yoquinin, normalization occurs without any side effects in the natural metabolic mechanism.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000086451-A
priorityDate 1996-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65781
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53384398
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544577
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3002820
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416215746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586922
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505403
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425772305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410422147
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6604902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590036
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226729203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414858671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553082
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439642
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4846
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419496809
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421035462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453803217
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3038639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID456201
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID63417
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453187150
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426068208
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID63417

Total number of triples: 66.